Still at 60% of $550m, ($330m), we can double our price from current $173m - if NPV is the right measure to value Galena by.
Seems like some upside still to come, provided production is bedded down and quarterly figures prove up to the model.
Ann: First Concentrate Produced at Abra, page-27
Add G1A (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| G1A (ASX) Chart |
Day chart unavailable